SCHEMBL18871771

SCHEMBL18871771

COC(=O)c1ccc(-c2ccc3c(c2)CCCN3C(C)=O)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B2 P19099 11/20 0.53
▸ CYP11B1 P15538 8/20 0.53
▸ KDM4E B2RXH2 2/20 0.46
▸ NOTUM Q6P988 2/20 0.46
▸ PDK1 Q15118 1/20 0.45
▸ PDK2 Q15119 1/20 0.45
▸ PDK3 Q15120 1/20 0.45
▸ PDK4 Q16654 1/20 0.45
▸ LMNA P02545 2/20 0.45
▸ TP53 P04637 1/20 0.45
▸ HSD17B3 P37058 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ STAT3 P40763 1/20 0.44
▸ STAT1 P42224 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ KLF5 Q13887 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18871984 0.87 CYP11B2 (0.56) CYP11B2CYP11B1NOTUMPDK1PDK2
SCHEMBL20429095 0.83 CYP11B2 (0.50) CYP11B2CYP11B1NOTUMLMNATP53
SCHEMBL18871783 0.83 CYP11B2 (0.51) CYP11B2CYP11B1NOTUMPDK1PDK2
SCHEMBL18871976 0.82 LMNA (0.58) CYP11B2CYP11B1KDM4ENOTUMPDK1
SCHEMBL20429098 0.81 CYP11B2 (0.47) CYP11B2CYP11B1NOTUMLMNATP53
SCHEMBL20429027 0.81 CYP11B2 (0.47) CYP11B2CYP11B1NOTUMLMNATP53
SCHEMBL18872002 0.81 CYP11B2 (0.49) CYP11B2CYP11B1NOTUMPDK1PDK2
SCHEMBL18871765 0.81 PDK1 (0.50) KDM4EPDK1PDK2PDK3PDK4
SCHEMBL18871999 0.80 CYP11B2 (0.48) CYP11B2CYP11B1NOTUMLMNATP53
SCHEMBL20429091 0.80 CYP11B2 (0.48) CYP11B2CYP11B1NOTUMPDK1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3168213-B1 TETRAHYDROQUINOLINE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE LLC (US) 2018-08-01 — — EP disclosed
EP-3168213-A1 TETRAHYDROQUINOLINE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS Glaxosmithkline LLC (US) 2017-05-17 — — EP disclosed
Send feedback